Rejuveinix

维生素C/维生素B12/盐酸硫胺素/核黄素磷酸钠/尼克酰胺/维生素B6/泛酸钙

Report date: 2025/07/25 14:29:56

Base Information

Drug NameRejuveinix
Drug Alias NameRJX
ClassificationSmall molecules
Mechanisms of ActionVitamin C supplementsMethylmalonyl-CoA Mutase stimulantsVitamin B1 supplements +[4] 
TargetsMethylmalonyl-CoA MutaseMitogen-activated protein kinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HypoxiaRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Ascorbic AcidCyanocobalaminThiamine Chloride Hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesReven Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReven Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)HypoxiaRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A